Yurong Lu

Prof. Dr. Yurong Lu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
HLHongjiao Li
Hongjiao Li
CXChenglian Xie
Chenglian Xie
YLYurong Lu
Yurong Lu
KCKaijing Chang
Kaijing Chang
Feng GuanFeng Guan
Feng Guan
XLXiang Li
Xiang Li
Cytarabine (Ara-C) has been one of the frontline therapies for clonal hematopoietic stem cell disorders, such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), but Ara-C resistance often occurs and leads to treatment failure. Exosomal microRNAs (miRNAs, miRs) as small noncoding RNA that play important roles in post-transcriptional gene regulation, can be delivered into recipient cells by exosomes and regulate target genes’ expression. miR92a has been reported to be dysregulated in many cancers, including MDS and AML. However, the effects of exosomal miR92a in hematologic malignancies have not been fully investigated. In this study, qualitative analysis showed the significantly enhanced expression of exosomal miR92a in MDS/AML plasma. Subsequent functional assays indicated that exosomal miR92a can be transported and downregulate PTEN in recipient cells and, furthermore, activate the Wnt/β-catenin signaling pathway and interfere with the Ara-C resistance of receipt MDS/AML cells in vitro and in vivo. Altogether, our findings offer novel insights into plasma exosomal miR92a participating in Ara-C resistance in MDS/AML and we propose miR92a as a potential therapeutic target for MDS/AML.

14 November 2023 in Research Square
Verified
Preprint
Open access
PDF file
JCJinhua Cao
Jinhua Cao
JWJinpeng Wu
Jinpeng Wu
NFNing Fan
Ning Fan
MGMiaomiao Ge
Miaomiao Ge
YLYurong Lu
Yurong Lu
Purpose Small extracellular vesicles (sEVs) have emerged as critical mediators of intercellular communication, capable of shuttling functional molecules from donor to recipient cells. Their direct impact on target cells can profoundly influence local and systemic environments, thereby promoting cancer growth and metastasis. Although several studies have explored the relationship between sEVs and various types of cancer, only few studies have been conducted on bladder cancer specifically.Methods This study used an in vitro approach and multiple assays to investigate whether melatonin affects catenin delta 1 (CTNND1) transmission through sEVs and how CTNND1 regulates the growth and migration of bladder urothelial carcinoma (BLCA) cells.Results We observed significantly elevated CTNND1 levels in BLCA cells. CTNND1 secreted by these cells could be delivered to recipient cells via sEVs. We further uncovered significant alterations in cellular behaviors upon delivery of sEVs, namely in terms of proliferation and migration. By delineating the biological functions of CTNND1 in BLCA cells, we have unveiled the potential of modulating CTNND1 expression as a promising avenue for clinical therapeutic intervention.Conclusion Our findings shed light on the intricate interplay between sEV-mediated cargo transfer and the regulation of CTNND1, offering valuable insights into novel therapeutic strategies for BLCA.